- Global Pharma News & Resources

Global Antibiotics Market (2015-2027), By Product Type , By Distribution Channel, By Country, Competition, Forecast & Opportunities by Proficient Market

At Proficient Market, Global Antibiotics Market research report presents a comprehensive overview of market size, share, evolution, trends, and forecast, and growth opportunities of antibiotics market by product type, application, key manufacturers and key regions and countries. This report offers comprehensive analysis on global antibiotics market along with, market trends, drivers, and restraints of the antibiotics market. In-depth study of market size with data Tables, Bar & Pie Charts, and Graphs & Statistics which helps easy to understand detailed breakdown of market.

According to the report, Global Antibiotics Market in 2019 stood at USD 46.37 billion and is expected to reach USD 53.07 billion by 2027 growing at a CAGR of 1.5% from 2020 to 2027.

Available Sample Report in PDF Version along with Graphs and Figures@

Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. Antibiotics are also known as antibacterial or antimicrobials. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been used to treat several bacterial infections.

Antibiotics Market Key Players: The research study includes profiles of leading companies operating in the global antibiotic market. Key players profiled in the report include:
AstraZeneca plc
Bristol-Myers Squibb Co.
Bayer HealthCare AG
GlaxoSmithKline plc
Eli Lilly and Company
Johnson & Johnson
Merck & Co.
Novartis AG
Teva Pharmaceutical Industries Ltd.

GlaxoSmithKline plc announced that patient dosing has begun in a phase III clinical program investigating Gepotidacin, the first in a new chemical class of antibiotics called Triazaacenaphthylene bacterial topoisomerase inhibitors, in patients with uncomplicated urinary tract infection (UTI, also known as acute cystitis) and urogenital gonorrhea (GC).

Place Inquiry for Buying or Customization of Report:

Drivers for the Global Antibiotics Market: The growth of the antibiotics is driven by the development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials. Additionally, increase in incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are the other factors propelling the market. Substantial investments in research and development by biotech companies is propelling the global antibiotics market. Moreover, favorable government legislations is fueling the growth of the antibiotics market.

Opportunities for the Global Antibiotics Market: The antibiotics market is expected to exhibit significant growth during the forecast period, due to rise in demand for new generation antibiotics that can resolve the issue of antimicrobial resistance. In addition, development of novel approaches for new antibiotics for treating bacterial infections and increase in number of clinical trials supplement the growth of the antibiotics market. While, the discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections are expected to provide new opportunities for market players in the near future.

Restrains for the Global Antibiotics Market: The development of antibiotic resistance, is driven by  the misuse of antibiotics which is hampering the growth of the antibiotics market.  While the time taken for the regulatory approval restraining the market growth. However, the  lack of research & development activity for the development of newer molecules are hampering the growth of the antibiotics market. Thus all these factors are restraining the growth of the antibiotics market.

Region Wise, Global Antibiotics Market Analysis: Report covers the region wise analysis, global antibiotics market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, Asia Pacific leads the global antibiotics market share followed by North-America  and Europe. While the  Asia Pacific leads the global antibiotics market due to the prevalence of various infectious diseases, favorable regulatory reforms, increase in population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines. All these factors led to the growth of the antibiotics market in Asia-Pacific region.

Access Full Report, here:

Global Antibiotics Market: Product analysis
Beta-lactams ( penicillin, carbapenems, and cephalosporin)

On the basis of type, Quinolones/fluoroquinolones accounted for largest share of total revenue generated due to the surge in demand for broad-spectrum property. While its bactericidal activity is the key factor for the growth of the segment. Moreover, the new generation quinolones enhanced oral bioavailability along with superior tissue penetration; and improved safety & tolerability. These advantages are increasing the demand for this segment which is boosting the antibiotics market.

Global Antibiotics Market: Application analysis
Specialty Clinics

The demand of Global Antibiotics Market is highest from Hospitals, due to  the presence of hospitals worldwide and increasing health issues led to increase in the demand for antibiotics. While favorable regulations, improvement in infrastructure, increasing economic conditions, awareness amongst people led to fueling the growth of the hospitals which is boosting the antibiotics market.

Global Antibiotics Market Market: Region analysis
North America: U.S., Canada, Mexico
Europe: U.K., France, Germany, Spain, Italy, Rest of Europe
Asia Pacific: China, Japan, South Korea, ASEAN, India
Rest of Asia Pacific: Latin America, Brazil, Argentina, Colombia, Rest of L.A.
Middle East and Africa: Turkey, GCC, UAE, South Africa, Rest of Middle East

The report can be customized as per client requirements. For further queries, you can contact us on or +1-773-800-2974. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Read the full press release and latest news of this report, here:

About Us:
Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialists with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever-new fun research methods developed by our team.

Contact Us:
Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 07-Apr-2020